Actualités Anebulo Pharmaceuticals Inc - ANEB | Actions NASDAQ | ADVFN

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Anebulo Pharmaceuticals Inc (ANEB)
Anebulo Pharmaceuticals Inc (ANEB) Actualités

Anebulo Pharmaceuticals Inc (ANEB)

1,14

0,06

(5,56%)

À la fermeture: 26 Avril 10:00PM

Retardé de 15 minutes

1,14

0,00

( 0,00% )

Après les heures de négociation: 10:07PM

Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

Form S-3 - Registration statement under Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute...

Form 8-K - Current report

Form 8-K - Current report

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Anebulo Pharmaceuticals

Vontobel Financial Produ...

Vontobel Financial Produ...

SG Issuer Societe Generale

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales